Xu Wenjie, Xu Haiyan, Yan Jie, Li Song, Yu Pengyun, Zhao Juan, Yang Fan, Wang Jianping
Shenzhen Salubris Pharmaceutical Co., Ltd., Shenzhen, Guangdong 518118, P. R. China.
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, P. R. China.
ACS Omega. 2024 Dec 4;9(50):49683-49691. doi: 10.1021/acsomega.4c07887. eCollection 2024 Dec 17.
Structurally knowing the active sites of a drug is important for understanding its therapeutic functions. S086 is a novel angiotensin receptor-neprilysin inhibitor that consists of the molecular moieties of EXP3174 (the active metabolite of the angiotensin receptor blocker losartan) and sacubitril (a neprilysin inhibitor prodrug) in a 1:1 molar ratio. There are two forms of cocrystals of S086, namely, ξ-crystal and α-crystal, which were formed both via intermolecular coordination bonding to calcium ions, with the aid of internal water. The binding state of multiple carboxyl anions (COO) to Ca of EXP3174 and sacubitril was examined in this study using infrared (IR) absorption spectroscopy, in which the asymmetric stretching () and symmetric stretching () modes of the COO groups were used as IR probes. Ultrafast two-dimensional (2D) IR spectroscopy was utilized for spectrally assigning the origin of multiple COO groups by the presence or absence of interchromophore vibrational coupling. Key structural variation between the two crystal forms was found: in the unit cell of ξ-crystal, the ratio of "bridging" and "bidentate" types of COO binding to Ca for four EXP3174 molecules is 2:2, while the ratio is predicted to be 3:1 in the case of α-crystal. However, in both crystals, four sacubitril molecules are believed to similarly form a "trident" type of COO binding to Ca. Our study demonstrates that linear and nonlinear IR spectroscopies can be used to characterize local crystal structures of drugs and reveal subtle difference between similar crystal structures.
从结构上了解药物的活性位点对于理解其治疗功能很重要。S086是一种新型血管紧张素受体-中性肽链内切酶抑制剂,由EXP3174(血管紧张素受体阻滞剂氯沙坦的活性代谢物)和沙库巴曲(一种中性肽链内切酶抑制剂前药)以1:1摩尔比组成的分子部分构成。S086有两种共晶体形式,即ξ-晶体和α-晶体,它们都是通过分子间与钙离子的配位键合,并借助内部水形成的。本研究使用红外(IR)吸收光谱法研究了EXP3174和沙库巴曲中多个羧基阴离子(COO)与钙的结合状态,其中COO基团的不对称伸缩()和对称伸缩()模式用作红外探针。利用超快二维(2D)红外光谱通过发色团间振动耦合的存在与否对多个COO基团的起源进行光谱归属。发现了两种晶体形式之间的关键结构差异:在ξ-晶体的晶胞中,四个EXP3174分子的COO与钙的“桥连”和“双齿”结合类型的比例为2:2,而在α-晶体的情况下预计比例为3:1。然而,在两种晶体中,四个沙库巴曲分子被认为类似地形成了一种与钙的COO“三叉戟”结合类型。我们的研究表明,线性和非线性红外光谱可用于表征药物的局部晶体结构,并揭示相似晶体结构之间的细微差异。